APIs
| Product | USDMF | CEP | EDMF | C-DMF | CA-DIF | KDMF | RUSSIA | ANVISA BRAZIL | Therapeutic Use |
|---|---|---|---|---|---|---|---|---|---|
| Aripiprazole | √ | √ | √ | √ | Antipsychotic agent | ||||
| Articaine Hcl | √ | √ | √ | Anaesthetic | |||||
| Atomoxetine Hcl | √ | √ | √ | √ | √ | ** | ADHD therapeutic agent | ||
| Baclofen | * | √ | √ | * | √ | √ | Skeletal muscle relaxant | ||
| Benserazide | √ | √ | Anti-Parkinsonian agent | ||||||
| Betahistine DiHcl | √ | √ | √ | * | √ | * | Anti-vertigo agent | ||
| Buspirone | √ | √ | Anti-anxiety | ||||||
| Calcium Acetate | √ | Phosphate binder | |||||||
| Cilostazol | * | Antiplatelet agent | |||||||
| Dabigatran Etexilate Mesylate | * | Anticoagulant | |||||||
| Dapagliflozin Propanediol Monohydrate | * | * | * | √ | * | Antidiabetic | |||
| Desvenlafaxine | * | Antidepressant | |||||||
| Dexmethylphenidate Hcl | ADHD therapeutic agent | ||||||||
| Diflunisal | √ | √ | NSAID agent | ||||||
| Dipyridamole | √ | √ | √ | √ | Antiplatelet | ||||
| Doxazosin Mesylate | √ | √ | √ | √ | √ | Antihypertensive | |||
| Drotaverine Hcl | √ | √ | √ | Antispasmodic | |||||
| Edoxaban | Anticoagulant | ||||||||
| Entacapone | √ | √ | √ | √ | √ | √ | Anti-parkinsonian agent | ||
| Epinastine | Antihistamine agent | ||||||||
| Fenoprofen | √ | NSAID | |||||||
| Flurbiprofen | √ | √ | √ | NSAID | |||||
| Fluvoxamine Maleate | √ | √ | √ | √ | * | Antidepressant | |||
| Glycopyrrolate | √ | √ | Anticholinergic agent | ||||||
| Hydralazine Hcl | √ | * | Antihypertensive | ||||||
| Hydroxyzine Pamoate | * | Antihistamine | |||||||
| Irinotecan HCl Trihydrate | * | √ | Oncology | ||||||
| Isosulfan Blue | √ | Diagnostic dye | |||||||
| L-Carglumic Acid | √ | Ammonia detoxicants | |||||||
| Lamotrigine | * | √ | √ | √ | √ | √ | √ | Antiepileptic agent | |
| Levodropropizine | √ | √ | Antitussive agent | ||||||
| Levomepromazine Maleate | √ | √ | Antipsychotic | ||||||
| Lercanidipine | * | Antihypertensive | |||||||
| Lisdexamfetamine dimesylate | * | * | ADHD | ||||||
| Lurasidone Hcl | * | Antipsychotic | |||||||
| Maraviroc | √ | HIV CCR5 antagonist | |||||||
| Mebeverine HCl | √ | √ | √ | √ | √ | Antispasmodic | |||
| Methylphenidate Hcl | √ | √ | * | √ | ADHD therapeutic agent | ||||
| Midazolam | √ | √ | √ | √ | √ | √ | √ | Sedative/ Anaesthetic | |
| Oxolamine Citrate | Antitussive agent | ||||||||
| Oxolamine Phosphate | Antitussive agent | ||||||||
| Oxymetazoline | * | Nasal decongestant | |||||||
| Pinaverium Bromide | ** | Antispasmodic agent | |||||||
| Pirfenidone | √ | √ | √ | √ | √ | Anti-inflammatory, antifibrotic | |||
| Posaconazole | √ | Antifungal agent | |||||||
| Probenecid | √ | Uricosuric agent | |||||||
| Propafenone | Antiarrhythmic agent | ||||||||
| Pyridostigmine Bromide | * | * | Cholinesterase inhibitor | ||||||
| Quetiapine Fumarate | √ | √ | √ | √ | √ | √ | √ | Antipsychotic agent | |
| Ractopamine HCl | * | √ | * | Animal feed additive | |||||
| Rivaroxaban | √ | √ | √ | √ | √ | √ | √ | * | Anticoagulant |
| Safinamide | Anti-parkinsonian agent | ||||||||
| Sulfasalazine | * | Anti-inflammatory agent | |||||||
| Tamsulosin Hcl | √ | √ | √ | √ | √ | √ | √ | Benign prostatic hyperplasia therapeutic agent | |
| Tapentadol Phosphate | * | Analgesic | |||||||
| Tapentadol HCl | * | Analgesic | |||||||
| Trientine | √ | Copper chelating agent | |||||||
| Trimebutine | * | √ | Gastroprokinetic agent | ||||||
| Trimetazidine dihydrochloride | √ | ** | Anti-anginal agent | ||||||
| Venlafaxine Hcl | * | √ | * | * | Antidepressant | ||||
| Zilpaterol | Animal feed additive | ||||||||
| Zonisamide | * | √ | √ | √ | Anticonvulsant |
√ Available / Approved * Filed / Awaiting Approval ** To be Filed
| Product | Therapeutic Use | Development Status |
|---|---|---|
| Acotiamide | Anti-Dyspepsia agent | Validation Completed |
| Apixaban | Anticoagulant | Validation Completed |
| Dexlansoprazole Sesquihydrate | Proton Pump Inhibitor | Under Validation |
| Erdosteine | Mucolytic Agent | Validation Completed |
| Indapamide | Antihypertensive | Under Validation |
| Isotretinoin | Anti-acne Agent | Under Optimization |
| Loxoprofen | Non-Steroidal Anti-Inflammatory agent | Validation Completed |
| Nintedanib Esylate | Anti-inflammatory, Antifibrotic | Under Validation |
| Remimazolam Besylate (Intermediate) | Sedative, General Anaesthetic | Validation Completed |
| Tegoprazan | Anti-Ulcer Agent | Under Optimization |
| Flurbiprofen (new route) | Non-Steroidal Anti-Inflammatory agent | Under Optimization |
| Vonoprazan Fumarate | Anti-Ulcer Agent | Under Optimization |
| Viloxazine HCl | ADHD Therapeutic Agent | Under Optimization |
| Trimebutine Base | Gastroprokinetic Agent | Under Validation |
| Clotrimazole | Antifungal Agent | Under Optimization |
| Doxylamine | Antihistamine | Under Optimization |
| Prazosin | Antihypertensive | Under Optimization |
| Alfuzosin | BPH Therapeutic Agent | Under Optimization |
| Terazosin | BPH Therapeutic Agent, Antihypertensive | Under Optimization |
| Serdexmethylphenidate Int. (SDS) | CNS Stimulant | Lab Validation |
| Serdexmethylphenidate Int. (SDP) | CNS Stimulant | Lab Validation |
Pellets
| Product | DMF / Tech Pack | Bioequivalence Established | Type of BE Study | RLD / Market | Stability | Brazil | Turkey | Mexico | MENA | APAC |
|---|---|---|---|---|---|---|---|---|---|---|
| Duloxetine HCl Delayed Release Pellets 20% (HPMC Acetyl Succinate) | DMF | Yes | Fasting & Fed | CYMBALTA / EU | Available -36 M | Yes | Yes | Yes | Yes | Yes |
| Duloxetine HCl Delayed Release Pellets 20% (HPMC Phthalate) | DMF / Tech Pack | Yes | Fasting & Fed | CYMBALTA / Turkey / EU | Available -36 M | No | No | No | No | Yes |
| Duloxetine Delayed Release Pellets 17% (HPMC Phthalate) | DMF / Tech Pack | No | No | – | Available -12 M | Yes | No | No | Yes | Yes |
| Itraconazole Immediate Release Pellets 21.74% | DMF | Yes | Fasting & Fed | SPORANOX / US | Available -36 M | No | No | Yes | No | Yes |
| Itraconazole Immediate Release Pellets 22% | DMF | No | No | – | Available -36 M | Yes | No | Yes | Yes | Yes |
| Venlafaxine HCl Extended Release Pellets 33% | Dossier / DMF | Yes | Fasting & Fed | EFFEXOR / EU | Available -36 M | Yes | Yes | Yes | Yes | Yes |
| Omeprazole Delayed Release Pellets 8.5% (LD-30) | Dossier / DMF | No | No | Available -36 M | No | No | Yes | Yes | Yes | |
| Omeprazole Delayed Release Pellets 8.5% (Phthalate) | Dossier / DMF | Yes | Fasting & Fed | Customer Established BE in Indonesia | Available -36 M | No | No | Yes | Yes | Yes |
| Tamsulosin Modified Release Pellets 0.12% | Dossier | Yes | Fasting & Fed | FLOMAX / US, SANDOZ / CANADA | Available -6 M | No | No | No | Yes | No |
| Tamsulosin HCl Modified Release Pellets 0.2% | DMF | No | No | FLOMAX / US | Available -36 M | Yes | Yes | Yes | Yes | Yes |
| Mebeverine HCl Sustained Release Pellets 80% | DMF | Yes | Fasting & Fed & MDD / SS | Colofac Retard 200 mg / EU | Available -36 M | Yes | Yes | No | Yes | Yes |
| Fenofibrate Sustained Release Pellets 75% | DMF | No | No | No | Available -36 M | Yes | No | No | Yes | No |
| Orlistat Immediate Release Pellets 50% (Extrudes) | DMF | No | No | Xenical / EU | Available -36 M | Yes | No | Yes | Yes | Yes |
| Lansoprazole Delayed Release Pellets 8.5% | DMF | Yes | Fasting & Fed | AGOPTON / EU | Available -36 M | Yes | Yes | Yes | Yes | Yes |
| Methylphenidate HCl Extended Release Pellets 11% | DMF / Tech Pack | Yes | Fasting & Fed | RITALIN LA / BR | Available -12 M | Yes | No | No | No | No |
| Methylphenidate HCl Immediate Release Pellets 11% | DMF / Tech Pack | Yes | Fasting & Fed | RITALIN LA / BR | Available -12 M | Yes | No | No | No | No |
| Product Name | DMF / Tech Pack | Bioequivalence Established | Type of BE Study | RLD / Mkt | Stability | Brazil | Turkey | Mexico | MENA | APAC |
|---|---|---|---|---|---|---|---|---|---|---|
| Duloxetine Hydrochloride Delayed Release Pellets 17% | Tech Pack | No | No | No | 6M data available | – | – | – | – | – |
| Trimetazidine Extended Release Pellets 55% | Tech Pack | No | No | VASTAREL MR / Brazil | 6M data available | Yes | – | – | – | – |
| Dabigatran Etexilate Pellets 35% | Tech Pack | No | Fast Single Dose Study | PRADAXA / US | 3M data available | – | – | – | Yes | – |
Finished Dosage Forms
| Product | Strength | ANDA (Approved/Filed) | EU Dossier (Approved/Filed) | ANDS (Approved/Filed) | Countries for which Dossier are available |
|---|---|---|---|---|---|
| Baclofen Tablets | 5mg | Approved | Not Filed | Except USA | |
| Baclofen Tablets | 10mg | Approved | Not Filed | Except USA | |
| Baclofen Tablets | 20mg | Approved | Not Filed | Except USA | |
| Cinacalcet tablets | 30 mg | Approved | Approved | Can be offered globally | |
| Cinacalcet tablets | 60 mg | Approved | Approved | Can be offered globally | |
| Cinacalcet tablets | 90 mg | Approved | Approved | Can be offered globally | |
| Doxazosin tablets | 1 mg | Filed | Not filed | Approved in CA | Except USA, Canada |
| Doxazosin tablets | 2 mg | Filed | Not filed | Approved in CA | Except USA, Canada |
| Doxazosin tablets | 4 mg | Filed | Not filed | Approved in CA | Except USA, Canada |
| Entecavir tablets film coated Tablets | 0.5mg | Approved | Approved | Approved in CA | Except CA, SEA, Middle east |
| Entecavir tablets film coated Tablets | 1 mg | Approved | Not filed | Except CA, SEA, Middle east | |
| Eplerenone Tablets | 25 mg | Filed | Not Filed | Except USA | |
| Eplerenone Tablets | 50 mg | Filed | Not Filed | Except USA | |
| Esclicarbazepine Tablets | 800 mg | Not filed | Approved | Except USA | |
| Itraconazole Capsules | 100 Mg | Approved | Not Filed | Except US, Aus, Canada | |
| Mebeverine HCl Tablets | 135 mg | Not filed | Approved | Approved in Aus | Except UK, Aus,Europe |
| Mebeverine SR Capsules | 200 mg | Not filed | Approved | Can be offered to USA and ROW | |
| Meclizine Tablets | 12.5 mg, 25 mg | Not filed | Not filed | Globally except Aus & New Zealand | |
| Metaxalone tablet | 800 mg | Approved | Not Filed | Can be offered globally | |
| Methocarbamol Tablets | 500 mg | Approved | Not Filed | Except USA | |
| Methocarbamol Film Coated Tablets | 750 mg | Approved | Approved | Except USA, Germany | |
| Posaconazole DR Tablets | 100 mg | Filed | Not filed | Except USA, Middle East | |
| Propiomazin Tablets | 25 mg | Not filed | Approved | Except Scandivian countries | |
| Tamsulosine HCl Capsules | 0.4 mg | Approved | Not Filed | Approved in CA | Can be offered globally |
| Tetracycline HCL Capsules | 250 mg | Approved | Not Filed | Except USA | |
| Tetracycline HCL Capsules | 500 mg | Approved | Not Filed | Except USA | |
| Tolcapone tablets | 100 Mg | Approved | Approved | Except USA and Europe |
Show More
| Product | Strength | Status |
|---|---|---|
| FERRIC CITRATE Tablets | EQ210 IRON | Proof of concept established |
| Aspirin+Dipyridamole ER Capsules | 25/200mg | Proof of concept established |
| Mexiletine Capsules | 150mg/200mg/250mg | Proof of concept established |
| Diflunisal tablets | 500 mg | Proof of concept established |
| Dipyridamole ER capsules | 200 mg | Proof of concept established |
| Solifenacin & Tamsulosin PR tablets | 6 mg/0.4 mg | Proof of concept established |
| Hydralazine HCl tablets | 10 mg, 25 mg, 50 mg and 100 mg | Proof of concept established |
| Tamsulosin MR tablets | 0.4mg | Under development |
| Methylphenidate HCl ER Capsules | 10 mg ,20 mg , 30 mg and 40 mg | Under development |
| Dabigatran etexilate Capsules | 75 mg, 110 mg, 150 mg | Under development |
| Dexlansoprazole DR capsules | 30 mg and 60 mg | Under development |
| Trimetazidine MR Tablets | 35 mg | Under development |
| Hydralazine HCl + Isosorbide Dinitrate tablets | 37.5mg/20mg | Under development |
| Galantamine ER Capsules | 8mg/16mg/24mg | Under development |
| Levodopa + Benserazide Dispersible Tablets | 50mg + 12.5mg, 100mg +25mg | Under development |
| Levodopa + Benserazide IR Capsules | 50mg + 12.5mg, 100mg + 25mg, 200mg + 50mg | Under development |
| Levodopa + Benserazide IR Tablets | 50mg + 12.5mg, 100mg + 25mg, 200mg + 50mg | Under development |
| Levodopa + Benserazide PR Capsules | 100mg + 25mg, 200mg + 50mg | Under development |
| Levodopa + Benserazide ER Tablets | 200mg + 50mg | To be initiated |
| Trimetazidine IR Tablets | 20 mg | To be initiated |
| Nafronyl MR Tabs | 100 mg | To be initiated |
| Aripiprazole ODT | 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg | To be initiated |
| Betahistine tablets | 8mg, 16mg, 24mg | To be initiated |
| Fluvoxamine Maleate Tablets | 25 mg, 50 mg, 100 mg | To be initiated |
| Fluvoxamine Maleate ER Capsules | 100 mg, 150 mg | To be initiated |
| Lamotrigine Dispersible /Chewable tabs | 2mg, 5mg, 25mg,100mg | To be initiated |
| Bempedoic Acid Tablets | 180mg | To be initiated |
| Lisdexamfetamine dimesylate Capsules | 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 70mg | To be initiated |
Show More
Contact Us